Skip to main content
Industry News
Hydroxychloroquine shortages affecting lupus patients

A survey conducted by the Lupus Research Alliance, which included 334 patients with lupus from 42 states, Washington, D.C., and Puerto Rico, found that 31% of those polled had difficulty obtaining hydroxychloroquine refills, while 5% of respondents couldn't get a refill amid the coronavirus pandemic. The shortages of hydroxychloroquine began in March after the drug was touted as being useful in preventing or treating COVID-19.

Full Story: